Author: Donna K Arnett, Roger S Blumenthal, Michelle A Albert1, Andrew B Buroker2, Zachary D Goldberger3, Ellen J Hahn1, Cheryl Dennison Himmelfarb1, Amit Khera1, Donald Lloyd-Jones1, J William McEvoy1, Erin D Michos1, Michael D Miedema1, Daniel Muñoz1, Sidney C Smith Jr1, Salim S Virani1, Kim A Williams Sr1, Joseph Yeboah1, Boback Ziaeian4
1 ACC/AHA Representative.
2 Lay Representative.
3 ACC/AHA Task Force on Clinical Practice Guidelines Liaison.
4 Task Force Performance Measures Representative.
Date published: 2019 Sep 10
Other: Volume ID: 140 , Issue ID: 11 , Pages: e596-e646 , Special Notes: doi: 10.1161/CIR.0000000000000678. , Word Count: 140
Keywords: AHA Scientific Statements; LDL cholesterol; antihypertensive agents; aspirin; atherosclerosis; atherosclerotic cardiovascular disease; atrial fibrillation; behavior modification; behavior therapy; blood cholesterol; blood pressure; body mass index; cardiovascular; cardiovascular disease; cardiovascular team-based care; cholesterol; chronic kidney disease; coronary artery calcium score; coronary disease; coronary heart disease; cost; diabetes mellitus; diet; dietary fats; dietary patterns; dietary sodium; dyslipidemia; e-cigarettes; exercise; guidelines; health services accessibility; healthcare disparities; heart failure; hypertension; lifestyle; lipids; measurement; myocardial infarction; nicotine; nonpharmacological treatment; nutrition; physical activity; prejudice; primary prevention; psychosocial deprivation; public health; quality indicators; quality measurement; risk assessment; risk factors; risk reduction; risk reduction discussion; risk treatment discussion; risk-enhancing factors; secondhand smoke; sleep; smoking; smoking cessation; social determinants of health; socioeconomic factors; statin therapy; systems of care; tobacco; tobacco smoke pollution; treatment adherence; treatment outcomes; type 2 diabetes mellitus; waist circumference; weight loss.
PMID: 30879355 PMCID: PMC7734661 DOI: 10.1161/CIR.0000000000000678